Petros Pharmaceuticals Operating Margin Growth & History (PTPI)

Petros Pharmaceuticals's operating margin was −90.51% for fiscal 2024.

View full Petros Pharmaceuticals company overview

Petros Pharmaceuticals annual operating margin history

Petros Pharmaceuticals annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20242024-12-31−90.51%+143.37 pp
20232023-12-31−233.88%+98.49 pp
20222022-12-31−332.37%−101.32 pp
20212021-12-31−231.05%−50.27 pp
20202020-12-31−180.78%—

Petros Pharmaceuticals operating margin trends

Between the periods ended 2020-12-31 and 2024-12-31, Petros Pharmaceuticals's operating margin increased from −180.78% to −90.51%, a change of +90.27 percentage points. The latest reported quarter, Q4 2024, shows −79.62%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Petros Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about PTPI yet. Start the conversation.

Write the first post